NCT00988624
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +16 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Clinical trial condition
Explore clinical trials studying Neurocognitive Disorders. Study availability and eligibility vary by location and protocol.
NCT00988624
NCT00662922
NCT00105612
NCT00469456
NCT00224497
NCT00004845
NCT00000173
NCT00043849
NCT00017940